Q&A
Porton replacing older facilities with new biopharma development plant
Porton Biopharma has begun construction on a new bioprocess development and manufacturing facility in the UK equipped with fermentation and down-stream processing suites.
Archives for June 27, 2016
Kite opens commercial CAR T-cell plant ahead of anticipated 2017 therapy launch
Kite Pharma has opened a T-cell manufacturing facility in California it says can overcome the logistical problems of autologous therapies and treat up to 5,000 patients per year.
Update
Pfizer and GE team on $350m modular biosimilars plant in China
Pfizer has struck a strategic partnership with GE Healthcare to construct and equip a biomanufacturing centre focused on producing biosimilars for China.